99 related articles for article (PubMed ID: 24631783)
1. Risk classification of cancer survival using ANN with gene expression data from multiple laboratories.
Chen YC; Ke WC; Chiu HW
Comput Biol Med; 2014 May; 48():1-7. PubMed ID: 24631783
[TBL] [Abstract][Full Text] [Related]
2. Cancer adjuvant chemotherapy strategic classification by artificial neural network with gene expression data: An example for non-small cell lung cancer.
Chen YC; Chang YC; Ke WC; Chiu HW
J Biomed Inform; 2015 Aug; 56():1-7. PubMed ID: 25998519
[TBL] [Abstract][Full Text] [Related]
3. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma.
Guo L; Ma Y; Ward R; Castranova V; Shi X; Qian Y
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3344-54. PubMed ID: 16740756
[TBL] [Abstract][Full Text] [Related]
4. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
Sun Z; Wigle DA; Yang P
J Clin Oncol; 2008 Feb; 26(6):877-83. PubMed ID: 18281660
[TBL] [Abstract][Full Text] [Related]
5. Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.
Baty F; Facompré M; Kaiser S; Schumacher M; Pless M; Bubendorf L; Savic S; Marrer E; Budach W; Buess M; Kehren J; Tamm M; Brutsche MH
Am J Respir Crit Care Med; 2010 Jan; 181(2):181-8. PubMed ID: 19833826
[TBL] [Abstract][Full Text] [Related]
6. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
8. Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.
De Preter K; Vermeulen J; Brors B; Delattre O; Eggert A; Fischer M; Janoueix-Lerosey I; Lavarino C; Maris JM; Mora J; Nakagawara A; Oberthuer A; Ohira M; Schleiermacher G; Schramm A; Schulte JH; Wang Q; Westermann F; Speleman F; Vandesompele J
Clin Cancer Res; 2010 Mar; 16(5):1532-41. PubMed ID: 20179214
[TBL] [Abstract][Full Text] [Related]
9. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
10. Artificial neural networks--a method for prediction of survival following liver resection for colorectal cancer metastases.
Spelt L; Nilsson J; Andersson R; Andersson B
Eur J Surg Oncol; 2013 Jun; 39(6):648-54. PubMed ID: 23514791
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling on lung cancer outcome prediction: present clinical value and future premise.
Sun Z; Yang P
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2063-8. PubMed ID: 17119029
[TBL] [Abstract][Full Text] [Related]
12. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data.
Gui J; Li H
Bioinformatics; 2005 Jul; 21(13):3001-8. PubMed ID: 15814556
[TBL] [Abstract][Full Text] [Related]
13. Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.
Marchevsky AM; Patel S; Wiley KJ; Stephenson MA; Gondo M; Brown RW; Yi ES; Benedict WF; Anton RC; Cagle PT
Mod Pathol; 1998 Jul; 11(7):618-25. PubMed ID: 9688182
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles in esophageal adenocarcinoma predict survival after resection.
Pennathur A; Xi L; Litle VR; Gooding WE; Krasinskas A; Landreneau RJ; Godfrey TE; Luketich JD
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):505-12; discussion 512-3. PubMed ID: 23321130
[TBL] [Abstract][Full Text] [Related]
15. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
[TBL] [Abstract][Full Text] [Related]
16. A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity.
Oh E; Choi YL; Park T; Lee S; Nam SJ; Shin YK
Breast Cancer Res Treat; 2012 Apr; 132(2):499-509. PubMed ID: 21667120
[TBL] [Abstract][Full Text] [Related]
17. SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment.
Shi M; He J
Mol Biosyst; 2016 Apr; 12(4):1214-23. PubMed ID: 26864276
[TBL] [Abstract][Full Text] [Related]
18. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
[TBL] [Abstract][Full Text] [Related]
19. CASPAR: a hierarchical bayesian approach to predict survival times in cancer from gene expression data.
Kaderali L; Zander T; Faigle U; Wolf J; Schultze JL; Schrader R
Bioinformatics; 2006 Jun; 22(12):1495-502. PubMed ID: 16554338
[TBL] [Abstract][Full Text] [Related]
20. A machine learning-based approach to prognostic analysis of thoracic transplantations.
Delen D; Oztekin A; Kong ZJ
Artif Intell Med; 2010 May; 49(1):33-42. PubMed ID: 20153956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
